This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction: Epithelial-Mesenchymal Transition Markers and HER3 Expression Are Predictors of Elisidepsin Treatment Response in Breast and Pancreatic Cancer Cell Lines
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMedicinal Plant Pharmacodynamics Research · Antimicrobial Peptides and Activities · Molecular Biology Techniques and Applications
After this article [1] was published, concerns were raised about results reported in Figs 2–5.
Specifically:
The authors did not respond to queries about the experiments in Figs 2–5.
In light of the unresolved concerns discussed above, the PLOS ONE Editors retract this article.
All authors either did not respond directly or could not be reached.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1TeixidóC, Marés R, Aracil M, Ramón y Cajal S, Hernández-Losa J (2013) Epithelial-Mesenchymal Transition Markers and HER 3 Expression Are Predictors of Elisidepsin Treatment Response in Breast and Pancreatic Cancer Cell Lines. P Lo S ONE 8(1): e 53645. 10.1371/journal.pone.0053645 23320098 PMC 3539985 · doi ↗ · pubmed ↗